Drug Profile


Alternative Names: (R)-BHCG; A 69992; BMS 180194; C-oxetanocin G; Cyclobut G; Cygalovir; SQ 33054; SQ 34514

Latest Information Update: 19 Feb 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Antiretrovirals; Hypoxanthines; Nucleosides; Small molecules
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cytomegalovirus infections; Hepatitis B; Herpes simplex virus infections; Herpes zoster

Most Recent Events

  • 19 Feb 1999 Discontinued-II for Cytomegalovirus infections in USA (Topical)
  • 19 Feb 1999 Discontinued-III for Hepatitis B in World (PO)
  • 19 Feb 1999 Discontinued-III for Herpes simplex virus infections in World (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top